American Portfolios Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$8.41K Buy
2,125
+1,625
+325% +$9.99K ﹤0.01% 2600
2022
Q2
$2.77K Hold
500
﹤0.01% 3034
2022
Q1
$7.34K Hold
500
﹤0.01% 2813
2021
Q4
$7.9K Sell
500
-198
-28% -$4.75K ﹤0.01% 2718
2021
Q3
$22.4K Buy
698
+76
+12% +$2.67K ﹤0.01% 2232
2021
Q2
$25.9K Sell
622
-340
-35% -$14K ﹤0.01% 2090
2021
Q1
$48.9K Buy
962
+862
+862% +$45.1K ﹤0.01% 1620
2020
Q4
$3.24K Buy
+100
New +$1.42K ﹤0.01% 2573

Other funds holding DMTK

American Portfolios Advisors's DMTK Position: Q3 2022 in Review

American Portfolios Advisors increased its DermTech, Inc. Common Stock (DMTK) stake by 325% in Q3 2022, buying an estimated $9.99K and bringing the position to 2,125 shares worth $8.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

American Portfolios Advisors first reported a position in DMTK in Q4 2020 and has held it in 8 quarters since. The position peaked at $48.9K in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • American Portfolios Advisors held 2,125 shares of DermTech, Inc. Common Stock worth $8.41K as of Q3 2022.
  • American Portfolios Advisors bought 1,625 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $9.99K.
  • DermTech, Inc. Common Stock made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2600 holding.
  • American Portfolios Advisors first reported a position in DermTech, Inc. Common Stock in Q4 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's DermTech, Inc. Common Stock position peaked at $48.9K in Q1 2021.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.